St Jude Medical has announced expansion of its EnSite Precision cardiac mapping system limited market release in Europe and use of the new platform in more than 600 cases in nine countries since receiving CE mark in January 2016.
The mapping system is a next-generation platform designed to provide automation, flexibility and precision for tailored treatment in patients with cardiac arrhythmias. The launch constitutes introduction of an entirely new suite of technologies including innovations in hardware, catheters, surface electrodes (patches) and software features designed for improved ease of use. The system is currently available and expanding in select European countries as part of its initial launch and the company is currently pursuing US Food and Drug Administration (FDA) clearance of the system.
The EnSite Precision cardiac mapping system is used in ablation procedures to visualise and navigate catheters in the heart. According to a company release, the system provides highly detailed anatomical models and maps to enable diagnosis of a wide range of arrhythmias, guide therapy and provide expanded procedural options to tailor care for patients.
During this initial launch, the EnSite Precision cardiac mapping system was used in a variety of procedures, from simple to complex, including atypical flutter, paroxysmal and persistent atrial fibrillation and ventricular tachycardia.
“The EnSite Precision system is precise, reliable, accurate and it is fast. This is very important when it comes to the demands of today’s electrophysiologists, especially as we see more patients with complex substrate based arrhythmias,” says Gerhard Hindricks, director, Department of Electrophysiology, University of Leipzig Heart Center in Germany. “This is really what we need to push clinical electrophysiology forward to a better level of successful case execution.”
The company states that the system uses intelligent automation tools to enable faster, more accurate high-density maps with greater consistency across cases. Additionally, the system is flexible and enhances efficiency by allowing physicians to map heart chambers with any electrophysiology catheter and customise procedures to address the circumstances of each case. The company also claims that the system allows catheter navigation to occur with less fluoroscopy, thus reducing potential for risks associated with excessive radiation exposure.
“We developed the EnSite Precision system with insight from world-renowned electrophysiologists to encompass leading mapping capabilities,” says Srijoy Mahapatra, vice-president of clinical, medical and scientific affairs for St Jude Medical. “Providing a best-in-class mapping system combining speed and detail with precision and stability allows physicians to have the information they need to treat both straightforward and complex arrhythmias.”